Targeting Fibroblasts in Fibrosis and Cancer

Ahmed M.R.H. Mostafa, Ruchi Bansal, Jai Prakash

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Fibroblasts are a heterogenic cell-type that play a major role in tissue integrity and wound healing. Under pathological conditions they transform into an aggressive phenotype, being responsible for inducing organ fibrosis as well as supporting tumor progression. Fibroblasts are known to secrete abundant amounts of extracellular matrix and numerous growth factors and cytokines. Cell-specific therapeutic targeting to fibroblasts is of high interest for intervening into several pathologies by developing novel therapeutic modalities. This chapter will shed light on the biology of fibroblasts, their diversity and heterogeneity as well as the targeting strategies using different targeting systems, such as nanoparticles and biologicals.

Original languageEnglish
Title of host publicationAnti-fibrotic Drug Discovery
EditorsJehrod Brenneman, Malliga R. Iyer
PublisherRoyal Society of Chemistry
Chapter11
Pages307-339
Number of pages33
ISBN (Electronic)978-1-83916-051-6, 978-1-78801-578-3
ISBN (Print)978-1-78801-510-3
DOIs
Publication statusPublished - 3 Mar 2020

Publication series

NameRSC Drug Discovery Series
Number73
Volume2020-January
ISSN (Print)2041-3203
ISSN (Electronic)2041-3211

Fingerprint

Dive into the research topics of 'Targeting Fibroblasts in Fibrosis and Cancer'. Together they form a unique fingerprint.

Cite this